SCHEMBL2066153

SCHEMBL2066153

NS(=O)(=O)c1c(Br)nc2ccc(C3CC3)nn12

nearest known ligand 0.35

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
CA1 P00915 5/20 0.35
CA2 P00918 5/20 0.35
CA9 Q16790 4/20 0.35
FYN P06241 1/20 0.35
CA12 O43570 3/20 0.33
CHRNA7 P36544 1/20 0.30
TNF P01375 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2067424 0.86 TNF (0.35) CA1CA2CA9FYNCA12
SCHEMBL2065980 0.86 FYN (0.35) FYN
SCHEMBL2067942 0.84 FYN (0.34) CA1CA2CA9FYNCA12
SCHEMBL2067058 0.75 FYN (0.36) FYNTNF
SCHEMBL2067926 0.74 AKT1 (0.34) CA1CA2CA9CA12TNF
SCHEMBL2065547 0.74 CA12 (0.30) CA1CA2CA9CA12TNF
SCHEMBL2066295 0.74 TNF (0.30) TNF
SCHEMBL2067049 0.73 FYN (0.34) FYN
SCHEMBL2066797 0.72 CA2 (0.33) CA2
SCHEMBL2066317 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8148524-B2 Process for producing sulfonyl chloride compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-04-03 US disclosed
EP-1932846-B1 METHOD FOR PRODUCING SULFONYL CHLORIDE COMPOUND SUMITOMO CHEMICAL CO (JP) 2010-10-27 EP disclosed
US-20090247748-A1 PROCESS FOR PRODUCING SULFONYL CHLORIDE COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-10-01 US disclosed
EP-1932846-A1 METHOD FOR PRODUCING SULFONYL CHLORIDE COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-06-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247748-A1 PROCESS FOR PRODUCING SULFONYL CHLORIDE COMPOUND SALL4, CLCN2, CLIC1 CA1 1402/4885CA2 176/4885CA9 760/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.